ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Takeda to sell Osaka headquarters ahead of Shire purchase

Sale aimed at beefing up finances for the planned $63bn acquisition

Takeda President and CEO Christophe Weber
Takeda President and CEO Christophe Weber 

TOKYO -- Takeda Pharmaceutical plans to sell its Osaka headquarters to bolster its finances ahead of the planned purchase of Irish drugmaker Shire for nearly 7 trillion yen ($63 billion) .

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more